US EditionPublished • loading... • Updated
Merck & Co., Inc. (NYSE:MRK) Upgraded to Outperform at Wolfe Research
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Merck & Co., Inc. (NYSE:MRK) Upgraded to Outperform at Wolfe Research
Merck & Co., Inc. (NYSE:MRK – Get Free Report) was upgraded by equities researchers at Wolfe Research from a “peer perform” rating to an “outperform” rating in a report issued on Thursday,Benzinga reports. The brokerage currently has a $135.00 target price on the stock. Wolfe Research’s price target would suggest a potential upside of 24.40% […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
